Marketing-authorisation holder
ACE Pharmaceuticals B.V.
46 medicines in 2 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 46
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 45 | 45 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Corticosteroids for systemic useSystemic hormonal preparations · ATC H02A
- Antibacterials for systemic useAnti-infectives for systemic use · ATC J01C
- Antihistamines for systemic useRespiratory system · ATC R06A
- Thyroid therapySystemic hormonal preparations · ATC H03A
- PsycholepticsNervous system · ATC N05C
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- ace
- ace pharmaceuticals b v
- ace pharmaceuticals bv
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 46
- Countries
- 2
- Roles
- Authorisation holder